WAO guideline for the management of hereditary angioedema

293Citations
Citations of this article
234Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and appropriate therapy are often unknown or not available for physicians and other health care providers. For this reason we convened a group of specialists that focus upon HAE from around the world to develop not only a consensus on diagnosis and management of HAE, but to also provide evidence based grades, strength of evidence and classification for the consensus. Since both consensus and evidence grading were adhered to the document meets criteria as a guideline. The outcome of the guideline is to improve diagnosis and management of patients with HAE throughout the world and to help initiate uniform care and availability of therapies to all with the diagnosis no matter where the residence of the individual with HAE exists. Copyright © 2012 by World Allergy Organization.

Cite

CITATION STYLE

APA

Craig, T., Pürsün, E. A., Bork, K., Bowen, T., Boysen, H., Farkas, H., … Maurer, M. (2012). WAO guideline for the management of hereditary angioedema. World Allergy Organization Journal, 5(12), 182–199. https://doi.org/10.1097/WOX.0b013e318279affa

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free